// November 28, 2023
FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards
This year has seen a flurry of activity by the U.S.
This year has seen a flurry of activity by the U.S.
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
USP’s Naiffer Romero has teamed up with researchers at LHASA Limited, AstraZeneca, Sai Life S